Pregnant women with mild COVID-19 followed in community setting by telemedicine, and factors associated with unfavorable outcome.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
24
06
2022
accepted:
05
07
2023
medline:
7
8
2023
pubmed:
3
8
2023
entrez:
3
8
2023
Statut:
epublish
Résumé
Few is known on pregnant women with mild COVID-19 managed in a community setting with a telemedicine solution, including their outcomes. The objective of this study is to evaluate the adverse fetal outcomes and hospitalization rates of pregnant COVID-19 outpatients who were monitored with the Covidom© telemedicine solution. A nested study was conducted on pregnant outpatients with confirmed COVID-19, who were managed with Covidom© between March and November 2020. The patients were required to complete a standard medical questionnaire on co-morbidities and symptoms at inclusion, and were then monitored daily for 30 days after symptom onset. Adverse fetal outcome was defined as a composite of preterm birth, low birthweight, or stillbirth, and was collected retrospectively through phone contact with a standardized questionnaire. The study included 714 pregnant women, with a median age of 32.0 [29.0-35.0] and a median BMI of 23.8 [21.3-27.0]. The main comorbidities observed were smoking (53%), hypertension (19%). The most common symptoms were asthenia (45.6%), cough (40.3%) and headache (25.7%), as well as anosmia (28.4%) and agueusia (32.3%). Adverse fetal outcomes occurred in 64 (9%) cases, including 38 (5%) preterm births, 33 (5%) low birthweights, and 6 (1%) stillbirths. Hospitalization occurred in 102 (14%) cases and was associated with adverse fetal outcomes (OR 2.4, 95% CI 1.3-4.4). Our study suggests that adverse fetal outcomes are rare in pregnant women with mild COVID-19 who are monitored at home with telemedicine. However, hospitalization for COVID-19 and pregnancy-induced hypertension are associated with a higher risk of adverse fetal outcome.
Identifiants
pubmed: 37535653
doi: 10.1371/journal.pone.0288845
pii: PONE-D-22-18040
pmc: PMC10399733
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0288845Informations de copyright
Copyright: © 2023 Dinh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
JAMA Netw Open. 2020 Nov 2;3(11):e2029256
pubmed: 33211113
Clin Microbiol Infect. 2021 Aug;27(8):1158-1166
pubmed: 33915287
J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
BMJ. 2020 Jun 8;369:m2107
pubmed: 32513659
J Med Internet Res. 2020 Oct 22;22(10):e20748
pubmed: 33006938
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
BMC Pregnancy Childbirth. 2020 Dec 2;20(1):754
pubmed: 33267785
Obstet Gynecol. 2021 Apr 1;137(4):571-580
pubmed: 33560778
PLoS One. 2020 Jun 4;15(6):e0234187
pubmed: 32497090
CMAJ. 2021 Apr 19;193(16):E540-E548
pubmed: 33741725
JAMA Pediatr. 2021 Aug 1;175(8):817-826
pubmed: 33885740
Clin Infect Dis. 2021 Jul 15;73(Suppl 1):S17-S23
pubmed: 34021332
MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):264-270
pubmed: 35176002